Atopic Dermatitis Market Outlook and Overview by PBIPosted by venkatakiran on September 26th, 2019 Atopic Dermatitis Market Size and Growth Rate:
“The Atopic Dermatitis Market is burgeoning at prominent growth rate over the next seven years of forecast period 2019-2025 and expected to reach US$ 8,472.4 Mn by 2025, due to rise in number of atopic dermatitis cases around the globe” Atopic Dermatitis Market Growth Drivers and Restraints: For instance, according to research study, approximately 20% of children and 3% of adults are affected with atopic dermatitis around the world and the prevalence is gradually increasing especially in low-income countries. Moreover, frequent approvals from regulatory bodies for innovative therapeutics, strong product pipeline, and increase in healthcare expenditure are anticipated to boost the atopic dermatitis market over the forecast timeframe. However, stringent regulatory framework for product approval, patent expiry of block buster drugs, and poor economic growth in underdeveloped countries are the factors deter the atopic dermatitis market over the forecast timeframe. Browse More Details of the report @https://www.precisionbusinessinsights.com/market-reports/global-atopic-dermatitis-atopic-eczema-treatment-market/ Corticosteroids Expected to Dominate the Market Based on drug class, the atopic dermatitis market is segmented into corticosteroids, PDE-4 inhibitors, calcineurin inhibitors, antihistamines, antibiotics, biologics, and others. Corticosteroids segment dominate the global atopic dermatitis market and is growing at prominent growth rate over the forecast years owing to wide use of corticosteroids as first line therapy and better availability of the products in the market. Moreover, biologics segment has a lucrative opportunities over the forecast years owing to product approval and launch of newer biologics into market. For instance, in March 2019, Regeneron Pharmaceuticals and Sanofi received FDA approval for Dupixent (Dupilumab) for the treatment of moderate to severe atopic dermatitis in adolescents.
North America Accounts for Major Revenue Share for Atopic Dermatitis Market
Precision Business Insights (PBI), atopic dermatitis market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America contributed the largest share in global atopic dermatitis market and the market is expected to grow at prominent growth rate over the forecast years due to frequent product approval, increase in the prevalence of atopic dermatitis in U.S. and Canada, and presence of huge number of market players in the region. For instance, according to National Eczema Association, approximately 9.6 Mn U.S. children have atopic dermatitis and one-third have moderate to severe disease. In addition, Europe atopic dermatitis market creates lucrative opportunities over the forecast years owing to increase in the incidence of atopic dermatitis and launch of newer products into market. Strategic Product Pipeline and Launch of Newer Products in Atopic Dermatitis Market
Key player’s profiles in the report are Pfizer, Inc., Regeneron Phramaceuticals, Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb, Inc., Allergan plc, Astellas Pharma, Inc., Bayer AG, Galderma S.A., and Anacor Pharmaceuticals, Inc. Avail Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=15502 Detailed Segmentation of Atopic Dermatitis Market:
By Drug Class o Corticosteroids o PDE-4 Inhibitors o Calcineurin Inhibitors o Antihistamines o Antibiotics o Biologics o Others By Route of Administration o Oral o Topical o Parenteral By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies Geography o North America o Europe o Asia-Pacific o Latin America o Middle East and Africa (MEA) About Us: Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights. Contact Us: Shreya Paul Senior Business Development Executive Email @ shreya@precisionbusinessinsights.com Call @ +1-866-598-1553 Precision Business Insights Like it? Share it! More by this author |